Trafalgar International (GCAN) Other Non-Current Liabilities (2016 - 2021)
Greater Cannabis Company (GCAN) posted quarterly Other Non-Current Liabilities of $260905.0 for Q1 2021, down 84.69% year-over-year from $1.7 million in Q1 2020, and up 1395.93% quarter-over-quarter from $17441.0 in Q4 2020.
Trafalgar International (GCAN) Other Non-Current Liabilities (2016 - 2021) Analysis & Trends
Greater Cannabis Company's Other Non-Current Liabilities history runs 6 years deep, the most recent figure standing at $260905.0 for Q1 2021.
- In Q1 2021, Other Non-Current Liabilities fell 84.69% year-over-year to $260905.0; the TTM figure through Mar 2021 stood at $260905.0 (down 84.69% YoY), while the FY2020 annual figure was $17441.0, changed 0.0% from the prior year.
- Other Non-Current Liabilities for Q1 2021 stood at $260905.0, up from $17441.0 in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $1.7 million in Q1 2020, with the low at $17441.0 in Q4 2019.
- The 5-year median for Other Non-Current Liabilities is $259142.0 (2018), against an average of $343527.9.
- The sharpest annual moves came in 2020 and 2021: Other Non-Current Liabilities soared 411.19% in 2020, then plunged 84.69% in 2021.
- Greater Cannabis Company's Other Non-Current Liabilities stood at $205403.0 in 2017, then plunged by 47.21% to $108427.0 in 2018, then tumbled by 83.91% to $17441.0 in 2019, then changed by 0.0% to $17441.0 in 2020, then soared by 1395.93% to $260905.0 in 2021.
- Business Quant data shows GCAN's Other Non-Current Liabilities at $260905.0 in Q1 2021, $17441.0 in Q4 2020, and $325935.0 in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Trafalgar International | 236,233.75 | 236,233.75 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 260,905.00 |
| Dec 31, 2020 | 17,441.00 |
| Sep 30, 2020 | 325,935.00 |
| Jun 30, 2020 | 539,686.00 |
| Mar 31, 2020 | 1.70 Mn |
| Dec 31, 2019 | 17,441.00 |
| Sep 30, 2019 | 251,367.00 |
| Jun 30, 2019 | 251,367.00 |
| Mar 31, 2019 | 333,432.00 |
| Dec 31, 2018 | 108,427.00 |
| Sep 30, 2018 | 482,667.00 |
| Jun 30, 2018 | 270,502.00 |
| Mar 31, 2018 | 259,142.00 |
| Dec 31, 2017 | 205,403.00 |
| Sep 30, 2017 | 124,731.00 |
| Dec 31, 2016 | 100,000.00 |